In this article, we are going to take a look at where Eton Pharmaceuticals, Inc. (NASDAQ:ETON) stands against the other stocks. After two years of substantial gains to record highs, exhaustion in ...

- Product has patent protection through 2044 - - Expected to be listed in the U.S. Food and Drug Administration’s (FDA) Orange Book upon the product’s approval – ...

Craig-Hallum analyst Chase Knickerbocker raised the firm’s price target on Eton Pharmaceuticals (ETON) to $23 from $18 and keeps a Buy rating on the shares. The firm is updating its model ...

Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on ...